Conference item
4DCT oesophageal tumour delineation in SCOPE2 – how is radiotherapy quality assurance beneficial?
- Abstract:
- 4DCT scanning in radiotherapy (RT) planning for distal oesophageal cancer enables the generation of patient specific target volumes by accounting for tumour motion. UK experience of this technique is increasing, facilitated by robust RT trial quality assurance (RTTQA) programmmes. We present outcomes to date of 4DCT RTTQA within the Study of Chemoradiotherapy in Oesophageal cancer including PET response and dose Escalation (SCOPE2), a currently recruiting phase II/III trial.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 966.3KB)
-
- Publisher copy:
- 10.1016/S0167-8140(18)31390-2
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- ESTRO 37 Journal website
- Volume:
- 127
- Pages:
- S608
- Host title:
- Radiotherapy and Oncology
- Publication date:
- 2018-06-18
- Acceptance date:
- 2018-02-09
- DOI:
- EISSN:
-
1879-0887
- ISSN:
-
0167-8140
- Source identifiers:
-
905644
Item Description
- Pubs id:
-
pubs:905644
- UUID:
-
uuid:18efbbb1-f4af-4426-9117-c898333a8923
- Local pid:
- pubs:905644
- Deposit date:
- 2018-10-30
Terms of use
- Copyright holder:
- Elsevier Ireland Ltd
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Elsevier Ireland Ltd. All rights reserved. Published under a Creative Commons license
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record